1 |
Cholesteatoma growth and proliferation: posttranscriptional regulation by microRNA-21.
62
46
|
Friedland DR...Cioffi JA
|
19672202 |
2009 |
2 |
Comparison of acquired cholesteatoma between pediatric and adult patients.
53
62
|
Dornelles Cde C...Alves SL
|
19322578 |
2009 |
3 |
Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas.
53
62
|
Juhasz A...Balazs M
|
19395987 |
2009 |
4 |
[Expression of matrix metalloproteinase-2,9 in cholesteatoma from different positions].
53
62
|
Wang J...Yu LS
|
19484988 |
2009 |
5 |
Laser-assisted cholesteatoma surgery: technical aspects, in vitro implementation and challenge of selective cell destruction.
53
62
|
Caffier PP...Sedlmaier B
|
18253741 |
2008 |
6 |
Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity.
53
62
|
Yamamoto-Fukuda T...Takahashi H
|
18246360 |
2008 |
7 |
Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma.
53
62
|
Suchozebrska-Jesionek D...Stryjecka-Zimmer M
|
19128667 |
2008 |
8 |
Establishment and characterization of an in vitro model for cholesteatoma.
53
62
|
Raynov AM...Park K
|
19434278 |
2008 |
9 |
[The expression of receptor activator nuclear factor-kappaB ligand and osteoprotegerin in cholesteatoma].
53
62
|
Ma Y...Ye S
|
18589796 |
2008 |
10 |
[Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
53
62
|
Zhang E...Gong S
|
17650819 |
2007 |
11 |
Survival signaling and terminal differentiation in cholesteatoma epithelium.
53
62
|
Huisman MA...Grote JJ
|
17453465 |
2007 |
12 |
[Expression and significance of nuclear factor-kappa B ligand and correlation factor in the tissue of otitis media with cholesteatoma].
53
62
|
Xia M...Xu A
|
17580719 |
2007 |
13 |
Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
53
62
|
Song JJ...Hwang SJ
|
17419529 |
2007 |
14 |
The localization of matrix metalloproteinases-8 and -13 in cholesteatoma, deep-meatal and post-auricular skin: a comparative analysis.
53
62
|
Mehta D...Banerjee AR
|
17364344 |
2007 |
15 |
Comparative cytokeratin distribution patterns in cholesteatoma epithelium.
53
62
|
Olszewska E...Sudhoff H
|
17128409 |
2007 |
16 |
The role of tumor necrosis factor-alpha (TNF-alpha) in bone resorption present in middle ear cholesteatoma.
53
62
|
Vitale RF...Ribeiro Fde A
|
17505610 |
2007 |
17 |
The role of S100A1 in external auditory canal cholesteatoma.
53
62
|
Naim R...Hormann K
|
16969478 |
2006 |
18 |
Expression of RANKL and OPG in middle ear cholesteatoma tissue.
53
62
|
Jeong JH...Park YW
|
16826057 |
2006 |
19 |
Association between human beta defensin expression and cholesteatoma formation.
53
62
|
Meyer JE...Maune S
|
16431059 |
2006 |
20 |
Terminal differentiation and mitogen-activated protein kinase signaling in human cholesteatoma epithelium.
53
62
|
Huisman MA...Grote JJ
|
16639284 |
2006 |
21 |
Characterization of patterns of expression of protein kinase C-alpha, -delta, -eta, -gamma and -zeta and their correlations to p53, galectin-3, the retinoic acid receptor-beta and the macrophage migration inhibitory factor (MIF) in human cholesteatomas.
53
62
|
Ghanooni R...Choufani G
|
16513304 |
2006 |
22 |
[Express of transforming growth factor alpha and beta1 in cholesteatoma tissue].
53
62
|
Li WR...Chen ZN
|
16874966 |
2005 |
23 |
Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.
53
62
|
Olszewska E...Sudhoff H
|
15754169 |
2005 |
24 |
[The expression and significance of human beta-defensin 2 in middle ear cholesteatoma epithelium].
53
62
|
Ren X...Xu M
|
16001900 |
2005 |
25 |
[Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
53
62
|
Liu Y...Zhang P
|
15830692 |
2005 |
26 |
[Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
53
62
|
Wang H...Su J
|
15620146 |
2004 |
27 |
[The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
53
62
|
Peng L...Liu A
|
15499989 |
2004 |
28 |
[The expression of matrix metalloproteinase-9 and tumor necrosis factor-alpha in cholesteatoma].
53
62
|
Li N...Dong M
|
15499988 |
2004 |
29 |
Epidermal growth factor expression in middle ear cholesteatoma.
53
62
|
Chi HP...Tsai SM
|
15481560 |
2004 |
30 |
Immunohistochemical investigations on external auditory canal cholesteatomas.
53
62
|
Adamczyk M...Jahnke K
|
14501442 |
2003 |
31 |
Expression of hypoxia inducible factor 1 alpha and Von Hippel Lindau protein in human middle ear cholesteatoma.
53
62
|
Adunka O...Kierner AC
|
12838021 |
2003 |
32 |
Gene expression analysis of human middle ear cholesteatoma using complementary DNA arrays.
53
62
|
Tokuriki M...Saito H
|
12792315 |
2003 |
33 |
Osteoclast stimulating and differentiating factors in human cholesteatoma.
53
62
|
Hamzei M...Sudhoff H
|
12616193 |
2003 |
34 |
Possible involvement of keratinocyte growth factor and its receptor in enhanced epithelial-cell proliferation and acquired recurrence of middle-ear cholesteatoma.
53
62
|
Yamamoto-Fukuda T...Koji T
|
12533693 |
2003 |
35 |
[Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].
53
62
|
Xu Y...Jin K
|
12725186 |
2003 |
36 |
Expression of beta-defensins in human middle ear cholesteatoma.
53
62
|
Park K...Choi HS
|
12701748 |
2003 |
37 |
[Expression of transforming growth factor-beta 1 matrix metalloproteinase-1 and its inhibitor in human middle ear cholesteatoma].
53
62
|
Yang X...Wang B
|
12768723 |
2002 |
38 |
[The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
53
62
|
Liu J...Jiang Z
|
12768791 |
2002 |
39 |
Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma--correlations with growth factor expression in vivo?
53
62
|
Schmidt M...Hoppe F
|
11769995 |
2001 |
40 |
The levels of retinoid RARbeta receptors correlate with galectin-1, -3 and -8 expression in human cholesteatomas.
53
62
|
Simon P...Darro F
|
11377877 |
2001 |
41 |
The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas.
53
62
|
Sheikholeslam-Zadeh R...Choufani G
|
11404618 |
2001 |
42 |
[Expression of matrix metalloproteinasa-2,9 in cholesteatoma and middle ear cancer].
53
62
|
Zhu W...Wang P
|
12761978 |
2001 |
43 |
Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.
53
62
|
Sudhoff H...Ryan AF
|
11078065 |
2000 |
44 |
Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.
53
62
|
Akimoto R...Baba S
|
10965261 |
2000 |
45 |
Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas.
53
62
|
Shibosawa E...Takahashi S
|
10993447 |
2000 |
46 |
Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts.
53
62
|
Schmidt M...Hoppe F
|
11073191 |
2000 |
47 |
Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.
53
62
|
Shieh TJ...Juan KH
|
10518363 |
1999 |
48 |
Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
53
62
|
Kojima H...Moriyama H
|
10406309 |
1999 |
49 |
Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
53
62
|
Tanaka Y...Moriyama H
|
10401849 |
1999 |
50 |
Transforming growth factor-alpha and rhinitis.
53
62
|
Lam SM...Ahn JM
|
10401853 |
1999 |